F757 in New York. Pick another state for the same tag.
Against expectation — 2025
New York cites F757 less often than its own record predicts
Versus expected share0.23×
0.23 times the national share — cited less often here than elsewhere.
Share of New York citations0.18%
Of every deficiency written in New York in 2025, this is the portion that was F757.
New York0.18%
National0.80%
Share of all citations that were F757.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What New York surveyors wrote
F757 findings written in New York, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
G · Actual harm, isolatedNovember 15, 2018
Based on interviews and record reviews conducted during the Abbreviated Survey (complaint #NY 256) at [MEDICAL CONDITION] Living Center completed on 11/15/18, it was determined that for one (Resident #1) of four residents reviewed for medications, the facility did not ensure each resident's drug regimen was free from unnecessary drugs. An unnecessary drug is any drug when used without adequate monitoring and in the presence of adverse consequences. Specifically, a resident receiving [MEDICATION NAME] (blood thinner) did not have blood levels (PT/INRs, [MEDICATION NAME] Time/International Normalized Ratio, a blood test that measures how long it takes blood to clot) obtained as ordered to prevent blood clots in the resident's extremities. …
D · No harm, potential for more than minimal, isolatedJune 30, 2026
Based on observation, record review and interviews, the facility failed to ensure that each resident's drug regimen was free from unnecessary medications, including ensuring that required clinical monitoring was completed to support safe and appropriate use of medications. This was evident in one (Resident #13) of five residents reviewed for unnecessary medications out of 29 total sampled residents. Specifically, the facility failed to ensure completion of recommended laboratory monitoring for a resident receiving Allopurinol (medication used to treat gout, which is a disease marked by a painful inflammation of the joints), despite a pharmacy consultant recommendation and physician acknowledgment to order the test.Cross Reference tag F711 Physician Visits Review Care/Notes/OrderThe… …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction